{"id":"W4402034013","doi":"10.1016/j.jaad.2024.07.1521","title":"A randomized phase 3b study evaluating the safety and efficacy of risankizumab in adult patients with moderate-to-severe plaque psoriasis with non-pustular palmoplantar involvement","year":2024,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Innovaderm (Canada)","funders":"AbbVie; Amgen","keywords":"Medicine; Plaque psoriasis; Dermatology; Psoriasis; Randomized controlled trial; Pustular psoriasis; Palmoplantar pustulosis; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002184114,0.001120453,0.002412058,0.0002809118,0.000393718,0.0008701153,0.0006733111,0.001336542,0.006479668],"category_scores_gemma":[0.00188949,0.0006132079,0.001330095,0.0003493317,0.000797273,0.0007178492,0.0003541044,0.002759065,0.001092178],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005863466,"about_ca_system_score_gemma":0.001779093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007845538,"about_ca_topic_score_gemma":0.002132338,"domain_scores_codex":[0.9992781,0.0004195948,0.00004026573,0.00009929246,0.00007622215,0.00008650851],"domain_scores_gemma":[0.9989711,0.000236926,0.0002569207,0.0000852963,0.00009536448,0.0003544736],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.966599,0.00952328,0.001201317,0.0004989138,0.0007656857,0.0000602309,0.0000589441,0.0002979527,0.004096358,0.00009894899,0.001389738,0.01540969],"study_design_scores_gemma":[0.9502672,0.04631413,0.002113779,0.00001872054,0.000173767,0.00005201693,0.00001049536,0.000254197,0.0001874077,0.00007344824,0.0005279953,0.000006950044],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730231,0.005287455,0.00158295,0.001098092,0.0005178675,0.01235769,0.002786461,0.0002856564,0.003060729],"genre_scores_gemma":[0.974659,0.002635928,0.003629269,0.002152654,0.0003342065,0.01118193,0.002297708,0.00004306895,0.003066308],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006479668,"threshold_uncertainty_score":0.02167672,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01485413248682736,"score_gpt":0.2970944960856032,"score_spread":0.2822403635987759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}